Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycine SCHEMBL3102650 | 1.00 | GLRA1 (0.62) | — | |
| Glycine SCHEMBL18205005 | 1.00 | GLRA1 (0.62) | — | |
| Glycine SCHEMBL27489498 | 1.00 | GLRA1 (0.62) | — | |
| Glycine SCHEMBL7783306 | 1.00 | GLRA1 (0.62) | — | |
| Glycine SCHEMBL7797250 | 0.92 | GLRA1 (0.53) | — | |
| Ether SCHEMBL5072098 | 0.85 | GLRA1 (0.46) | — | |
| Glycine SCHEMBL11288633 | 0.84 | — | — | |
| Glycine SCHEMBL1148008 | 0.84 | — | — | |
| Glycine SCHEMBL4169207 | 0.81 | — | — | |
| Glycine SCHEMBL11049991 | 0.81 | GLRA1 (0.62) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 219 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3644960-A1 | DISSOLVING FILM FOR DELIVERY OF A CLOSTRIDIAL DERIVATIVE | Allergan, Inc. (US) | 2020-05-06 | — | — | EP | claimed |
| WO-2019006098-A1 | DISSOLVING FILM FOR DELIVERY OF A CLOSTRIDIAL DERIVATIVE | ALLERGAN, INC. (US) | 2019-01-03 | — | — | WO | claimed |
| WO-2018210449-A1 | PREVENTION AND TREATMENT OF FIBROBLAST GROWTH FACTOR 23 (FGF23)-ASSOCIATED DISORDERS INCLUDING CHRONIC KIDNEY DISEASE (CKD) | VETERINÄRMEDIZINISCHE UNIVERSITÄT WIEN (AT) | 2018-11-22 | — | — | WO | claimed |
| EP-3160928-A1 | PROCESS FOR THE PREPARATION OF ETHYLENE GLYCOL FROM SUGARS | Haldor Topsøe A/S (DK) | 2017-05-03 | — | — | EP | claimed |
| WO-2016149818-A1 | DAIRY COMPOSITIONS | KRAFT FOODS GROUP BRANDS LLC (US) | 2016-09-29 | — | — | WO | claimed |
| EP-2968573-A1 | DYE FREE LIQUID THERAPEUTIC SOLUTION | NOVARTIS CONSUMER HEALTH, INC. (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2016001169-A1 | PROCESS FOR THE PREPARATION OF ETHYLENE GLYCOL FROM SUGARS | HALDOR TOPSØE A/S (DK) | 2016-01-07 | — | — | WO | claimed |
| EP-2961725-A1 | PROCESS FOR REMOVING FORMALDEHYDE FROM A COMPOSITION COMPRISING GLYCOLALDEHYDE | Haldor Topsøe A/S (DK) | 2016-01-06 | — | — | EP | claimed |
| WO-2014149939-A1 | DYE FREE LIQUID THERAPEUTIC SOLUTION | NOVARTIS CONSUMER HEALTH INC. (US) | 2014-09-25 | — | — | WO | claimed |
| WO-2014131743-A1 | PROCESS FOR REMOVING FORMALDEHYDE FROM A COMPOSITION COMPRISING GLYCOLALDHEDYDE | HALDOR TOPSØE A/S (DK) | 2014-09-04 | — | — | WO | claimed |
| WO-2012084978-A1 | (R)-2-(3-FLUORO-4-PHENYLPHENYL)PROPIONIC ACID FOR USE IN THE TREATMENT OF SKIN DISEASES | GALENPHARMA GMBH (DE) | 2012-06-28 | — | — | WO | claimed |
| US-20070065469-A1 | Liquid formulations with high concentration of human growth hormone (high) comprising glycine | BETZ MICHAEL | 2007-03-22 | — | — | US | claimed |
| EP-0820293-A1 | BIOACTIVE CONCENTRATE, ITS PRODUCING METHOD AND CERTAIN DRUG COMPOSITIONS CONTAINING ALSO CHONDROITIN SULPHATE | S.C.TEHMAN SRL (RO) | 1998-01-28 | — | — | EP | claimed |
| WO-1996032117-A1 | BIOACTIVE CONCENTRATE, ITS PRODUCING METHOD AND CERTAIN DRUG COMPOSITIONS CONTAINING ALSO CHONDROITIN SULPHATE | S.C. TEHMAN SRL (RO) | 1996-10-17 | — | — | WO | claimed |
| EP-0639047-A1 | HERBICIDAL COMPOSITIONS | KVK AGRO A/S (DK) | 1995-02-22 | — | — | EP | claimed |
| EP-0420729-A1 | Preparation of homogene plant suspension and suspension obtained thereby | LABORATOIRES ARDEVAL (FR) | 1991-04-03 | — | — | EP | claimed |
| EP-0270751-A2 | Electrolyte solution for use in electrodes for measuring ions and method for its manufacture | HORIBA, LTD. (JP) | 1988-06-15 | — | — | EP | claimed |
| EP-0118534-A1 | METHOD FOR DETERMINING -g(g)-GLUTAMYLTRANSFERASE ACTIVITY AND KITS CONTAINING A NOVEL SUBSTRATE SOLUTION FOR USE THEREIN. | BECKMAN INSTRUMENTS INC (US) | 1984-09-19 | — | — | EP | claimed |
| WO-1984000978-A1 | METHOD FOR DETERMINING gamma-GLUTAMYLTRANSFERASE ACTIVITY AND KITS CONTAINING A NOVEL SUBSTRATE SOLUTION FOR USE THEREIN | BECKMAN INSTRUMENTS INC (US) | 1984-03-15 | — | — | WO | claimed |
| EP-4367119-A1 | NOVEL BISPIDONE LIGANDS AND TRANSITION METAL COMPLEXES THEREOF | Umicore (BE) | 2024-05-15 | — | — | EP | disclosed |
| EP-4363805-A1 | FLOW SENSOR AND METHOD USING TEMPERATURE TO IMPROVE MEASUREMENTS FOR LOW RATES | Remoni Technologies RO SRL (RO) | 2024-05-08 | — | — | EP | disclosed |
| EP-4363806-A1 | ULTRASONIC FLOW SENSOR AND THERMAL ENERGY SENSOR WITH NON-INVASIVE IDENTIFICATION OF NO-FLOW AND IMPROVED ACCURACY | REMONI A/S (DK) | 2024-05-08 | — | — | EP | disclosed |
| EP-4359368-A1 | COMBINATION OF A PYRAZOLE AND A THIOPHOSPHORIC TRIAMIDE | WockLab GmbH & Co. KG (DE) | 2024-05-01 | — | — | EP | disclosed |
| EP-4346760-A1 | COMPOSITION COMPRISING CANNABIDIOL FOR APPLICATION IN A BODY CAVITY | CS Medica A/S (DK) | 2024-04-10 | — | — | EP | disclosed |
| EP-4347756-A1 | 1,4-BUTANEDIOL MONO- OR DIESTERS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2024-04-10 | — | — | EP | disclosed |
| WO-2024059286-A1 | GROWTH FACTOR FORMULATION | TOPIX PHARMACEUTICALS, INC. (US) | 2024-03-21 | — | — | WO | disclosed |
| EP-4326251-A1 | COMPOSITIONS COMPRISING CANNABIDIOL AND, OPTIONALLY, BISABOLOL | Symrise AG (DE) | 2024-02-28 | — | — | EP | disclosed |
| EP-4322911-A1 | A FRAGRANCE MIXTURE CONTAINING ISOCITRONELLOL | Symrise AG (DE) | 2024-02-21 | — | — | EP | disclosed |
| EP-4304354-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | BASF SE (DE) | 2024-01-17 | — | — | EP | disclosed |
| EP-4274858-A1 | A WATERBORNE POLYURETHANE-EPOXY RESIN BASED PRIMER COMPOSITION AND ITS PREPARATION METHOD THEREOF | BASF Coatings GmbH (DE) | 2023-11-15 | — | — | EP | disclosed |
| EP-4188096-A1 | NEW AGROCHEMICAL FORMULATIONS FOR FUSARICIDIN PRODUCING BACTERIA | BASF SE (DE) | 2023-06-07 | — | — | EP | disclosed |
| WO-2023096803-A1 | BATTERY PACK ASSEMBLY | NIKOLA CORPORATION (US) | 2023-06-01 | — | — | WO | disclosed |
| EP-4181881-A1 | ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING LIPID CONJUGATES | Universität Heidelberg (DE) | 2023-05-24 | — | — | EP | disclosed |
| EP-4175936-A1 | METHOXYPROPANOLS SEPARATION INCLUDING AZEOTROPIC DISTILLATION | BASF SE (DE) | 2023-05-10 | — | — | EP | disclosed |
| EP-4175981-A2 | ANTI-CTLA-4 BINDING PROTEINS AND METHODS OF USE THEREOF | Gigagen, Inc. (US) | 2023-05-10 | — | — | EP | disclosed |
| EP-4157918-A1 | AMPHOTERICALLY-MODIFIED OLIGOPROPYLENEIMINE ETHOXYLATES FOR IMPROVED STAIN REMOVAL OF LAUNDRY DETERGENTS | BASF SE (DE) | 2023-04-05 | — | — | EP | disclosed |
| EP-4149919-A1 | A FRAGRANCE COMPOSITION | Symrise AG (DE) | 2023-03-22 | — | — | EP | disclosed |
| WO-2023038661-A1 | TOPICAL ANALGESIC COMPOSITIONS AND METHODS OF USE | PS THERAPY, INC. (US) | 2023-03-16 | — | — | WO | disclosed |
| EP-4146199-A1 | PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEM | Quantum Genomics (FR) | 2023-03-15 | — | — | EP | disclosed |
| EP-4142681-A1 | ANHYDROUS COSMETIC COMPOSITION COMPRISING POLYOLS, MONOALCOHOLS, FATTY AMINES AND AT LEAST 0.1% OF CARBOXYLIC ACIDS | L'OREAL (FR) | 2023-03-08 | — | — | EP | disclosed |
| EP-4132464-A1 | 2-DEOXY-D-GLUCOSE FOR PREVENTION AND TREATMENT OF A VIRAL DISEASE, IN PARTICULAR OF COVID-19 | EXPLORATION INVEST PTE LTD (SG) | 2023-02-15 | — | — | EP | disclosed |
| US-20230040052-A1 | IMAGE FORMING METHOD AND PRINTED MATTER | RICOH COMPANY, LTD. (JP) | 2023-02-09 | — | — | US | disclosed |
| WO-2023281046-A1 | NOVEL BISPIDONE LIGANDS AND TRANSITION METAL COMPLEXES THEREOF | UMICORE (BE) | 2023-01-12 | — | — | WO | disclosed |
| WO-2023274476-A1 | ULTRASONIC FLOW SENSOR AND THERMAL ENERGY SENSOR WITH NON-INVASIVE IDENTIFICATION OF NO-FLOW AND IMPROVED ACCURACY | REMONI A/S (DK) | 2023-01-05 | — | — | WO | disclosed |
| WO-2023274474-A1 | FLOW SENSOR AND METHOD USING TEMPERATURE TO IMPROVE MEASUREMENTS FOR LOW RATES | REMONI A/S (DK) | 2023-01-05 | — | — | WO | disclosed |
| WO-2023274475-A1 | ULTRASONIC FLOW SENSOR AND THERMAL ENERGY SENSOR WITH NON-INVASIVE CORRECTION FOR CHANGE IN FLUID COMPOSITION AND IMPROVED ACCURACY | REMONI A/S (DK) | 2023-01-05 | — | — | WO | disclosed |
| WO-2022268777-A1 | COMBINATION OF A PYRAZOLE AND A THIOPHOSPHORIC TRIAMIDE | WOCKLAB GMBH & CO. KG (DE) | 2022-12-29 | — | — | WO | disclosed |
| WO-2022148805-A1 | A WATERBORNE POLYURETHANE-EPOXY RESIN BASED PRIMER COMPOSITION AND ITS PREPARATION METHOD THEREOF | BASF COATINGS GMBH (DE) | 2022-07-14 | — | — | WO | disclosed |
| EP-4025675-A1 | A PERFUME OIL MIXTURE | Symrise AG (DE) | 2022-07-13 | — | — | EP | disclosed |
| EP-3997057-A1 | 2-(2,4,5-TRIMETHYLCYCLOHEX-2-EN-1-YL)ACETALDEHYDE AND DERIVATIVES AND THEIR USE AS AROMA CHEMICALS | BASF SE (DE) | 2022-05-18 | — | — | EP | disclosed |
| EP-3990512-A1 | POLYOL COMPONENT AND USE THEREOF FOR THE PRODUCTION OF RIGID POLYURETHANE FOAMS | BASF SE (DE) | 2022-05-04 | — | — | EP | disclosed |
| EP-3982910-A1 | A COOLING PREPARATION | Symrise AG (DE) | 2022-04-20 | — | — | EP | disclosed |
| EP-3941434-A1 | PLANT PEPTIDES AND THEIR APPLICATIONS (II) | Symrise AG (DE) | 2022-01-26 | — | — | EP | disclosed |
| WO-2022013306-A1 | ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING LIPID CONJUGATES | Universität Heidelberg (DE) | 2022-01-20 | — | — | WO | disclosed |
| EP-3937883-A1 | SUNSCREEN COMPOSITIONS CONTAINING POROUS METAL OXIDE SPHERES | BASF SE (DE) | 2022-01-19 | — | — | EP | disclosed |
| EP-3938054-A1 | A METHOD FOR IMPROVING THE PERFORMANCE OF A FRAGRANCE OR A FRAGRANCE MIXTURE | Symrise AG (DE) | 2022-01-19 | — | — | EP | disclosed |
| EP-3938055-A1 | AN ANTIMICROBIAL MIXTURE | Symrise AG (DE) | 2022-01-19 | — | — | EP | disclosed |
| WO-2022006557-A2 | ANTI-CTLA-4 BINDING PROTEINS AND METHODS OF USE THEREOF | GIGAGEN, INC. (US) | 2022-01-06 | — | — | WO | disclosed |
| WO-2022003032-A1 | METHOXYPROPANOLS SEPARATION INCLUDING AZEOTROPIC DISTILLATION | BASF SE (DE) | 2022-01-06 | — | — | WO | disclosed |
| EP-3927782-A1 | AN ANTI-RUST COMPOSITION FOR METAL SURFACE AND A METHOD OF ANTI-RUST TREATMENT ON METAL SURFACE | Chemetall GmbH (DE) | 2021-12-29 | — | — | EP | disclosed |
| WO-2021239547-A1 | AMPHOTERICALLY-MODIFIED OLIGOPROPYLENEIMINE ETHOXYLATES FOR IMPROVED STAIN REMOVAL OF LAUNDRY DETERGENTS | BASF SE (DE) | 2021-12-02 | — | — | WO | disclosed |
| EP-3911159-A1 | AN ANTIMICROBIAL MIXTURE | Symrise AG (DE) | 2021-11-24 | — | — | EP | disclosed |
| WO-2021228840-A1 | A FRAGRANCE COMPOSITION | SYMRISE AG (DE) | 2021-11-18 | — | — | WO | disclosed |
| WO-2021224354-A1 | PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEM | QUANTUM GENOMICS (FR) | 2021-11-11 | — | — | WO | disclosed |
| WO-2021219547-A1 | ANHYDROUS COSMETIC COMPOSITION COMPRISING POLYOLS, MONOALCOHOLS, FATTY AMINES AND AT LEAST 0.1% OF CARBOXYLIC ACIDS | L'OREAL (FR) | 2021-11-04 | — | — | WO | disclosed |
| EP-3877494-A1 | AN ANTIMICROBIAL SURFACTANT BASED COMPOSITION | Symrise AG (DE) | 2021-09-15 | — | — | EP | disclosed |
| WO-2021148304-A1 | PPO FORMULATIONS CONTAINING ETHER SULFATES | BASF SE (DE) | 2021-07-29 | — | — | WO | disclosed |
| EP-3852713-A1 | COMPOSITIONS COMPRISING ODORLESS 1,2-PENTANEDIOL | Symrise AG (DE) | 2021-07-28 | — | — | EP | disclosed |
| EP-3843547-A1 | ANTIMICROBIAL MIXTURES COMPRISING AT LEAST ONE HYDROXYPHENONE DERIVATIVE | Symrise AG (DE) | 2021-07-07 | — | — | EP | disclosed |
| WO-2021122558-A1 | SUBSTITUTED 4-METHYLENE-TETRAHYDROPYRANS, 4-METHYL-DIHYDROPYRANS AND 4-METHYL-TETRAHYDROPYRANS AND USE THEREOF AS AROMA CHEMICALS | BASF SE (DE) | 2021-06-24 | — | — | WO | disclosed |
| EP-3829511-A1 | FLUID-ABSORBENT CORE | BASF SE (DE) | 2021-06-09 | — | — | EP | disclosed |
| EP-3827472-A1 | AQUEOUS HEAT TRANSFER SYSTEM AND METHOD OF DISPERSING HEAT FROM ELECTRICAL COMPONENTRY | The Lubrizol Corporation (US) | 2021-06-02 | — | — | EP | disclosed |
| WO-2020057761-A9 | COMPOSITIONS COMPRISING ODORLESS 1,2-PENTANEDIOL | SYMRISE AG (DE) | 2021-05-06 | — | — | WO | disclosed |
| WO-2021043585-A1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2021-03-11 | — | — | WO | disclosed |
| EP-3775020-A1 | USE OF AN ULTRAVIOLET RADIATION ABSORBING COMPOSITION AS A LIGHT STABILIZER FOR A SHAPED ARTIFICIAL POLYMER ARTICLE | BASF SE (DE) | 2021-02-17 | — | — | EP | disclosed |
| WO-2021005109-A1 | 2-(2,4,5-TRIMETHYLCYCLOHEX-2-EN-1-YL)ACETALDEHYDE AND DERIVATIVES AND THEIR USE AS AROMA CHEMICALS | BASF SE (DE) | 2021-01-14 | — | — | WO | disclosed |
| EP-3758515-A1 | AEROSOL GENERATION | Nicoventures Trading Limited (GB) | 2021-01-06 | — | — | EP | disclosed |
| WO-2020260235-A1 | POLYOL COMPONENT AND USE THEREOF FOR THE PRODUCTION OF RIGID POLYURETHANE FOAMS | BASF SE (DE) | 2020-12-30 | — | — | WO | disclosed |
| WO-2020249216-A1 | A COOLING PREPARATION | SYMRISE AG (DE) | 2020-12-17 | — | — | WO | disclosed |
| EP-3746289-A2 | SIMULTANEOUS OPTIMIZATION OF FIBER SIZING IN-LINE WITH THE PULTRUSION PROCESS | BASF SE (DE) | 2020-12-09 | — | — | EP | disclosed |
| WO-2020243702-A2 | RNAI CONSTRUCTS FOR INHIBITING SCAP EXPRESSION AND METHODS OF USE THEREOF | AMGEN INC. (US) | 2020-12-03 | — | — | WO | disclosed |
| EP-3716994-A1 | COMPOSITIONS AND METHODS FOR CANCER THERAPY | Board of Regents of the University of Texas System (US) | 2020-10-07 | — | — | EP | disclosed |
| WO-2020192864-A1 | PLANT PEPTIDES AND THEIR APPLICATIONS (II) | SYMRISE AG (DE) | 2020-10-01 | — | — | WO | disclosed |
| WO-2020182288-A1 | A METHOD FOR IMPROVING THE PERFORMANCE OF A FRAGRANCE OR A FRAGRANCE MIXTURE | SYMRISE AG (DE) | 2020-09-17 | — | — | WO | disclosed |
| WO-2020182318-A1 | AN ANTIMICROBIAL MIXTURE | SYMRISE AG (DE) | 2020-09-17 | — | — | WO | disclosed |
| WO-2020182936-A1 | SUNSCREEN COMPOSITIONS CONTAINING POROUS METAL OXIDE SPHERES | BASF SE (DE) | 2020-09-17 | — | — | WO | disclosed |
| WO-2020147953-A1 | AN ANTIMICROBIAL MIXTURE | SYMRISE AG (DE) | 2020-07-23 | — | — | WO | disclosed |
| WO-2020057761-A1 | COMPOSITIONS COMPRISING ODORLESS 1,2-PENTANEDIOL | SYMRISE AG (DE) | 2020-03-26 | — | — | WO | disclosed |
| WO-2020043269-A1 | ANTIMICROBIAL MIXTURES COMPRISING AT LEAST ONE HYDROXYPHENONE DERIVATIVE | SYMRISE AG (DE) | 2020-03-05 | — | — | WO | disclosed |
| EP-3615584-A1 | RESINS DERIVED FROM RENEWABLE SOURCES AND STRUCTURES MANUFACTURED FROM SAID RESINS | Bio Bond ApS (DK) | 2020-03-04 | — | — | EP | disclosed |
| WO-2020025401-A1 | FLUID-ABSORBENT CORE | BASF SE (DE) | 2020-02-06 | — | — | WO | disclosed |
| WO-2020023642-A1 | AQUEOUS HEAT TRANSFER SYSTEM AND METHOD OF DISPERSING HEAT FROM ELECTRICAL COMPONENTRY | THE LUBRIZOL CORPORATION (US) | 2020-01-30 | — | — | WO | disclosed |
| WO-2019192943-A1 | USE OF AN ULTRAVIOLET RADIATION ABSORBING COMPOSITION AS A LIGHT STABILIZER FOR A SHAPED ARTIFICIAL POLYMER ARTICLE | BASF SE (DE) | 2019-10-10 | — | — | WO | disclosed |
| WO-2019149672-A2 | SIMULTANEOUS OPTIMIZATION OF FIBER SIZING IN-LINE WITH THE PULTRUSION PROCESS | BASF SE (DE) | 2019-08-08 | — | — | WO | disclosed |
| EP-3478283-A1 | USE OF NEUROKININ-1 ANTAGONISTS TO TREAT A VARIETY OF PRURITIC CONDITIONS | Menlo Therapeutics Inc. (US) | 2019-05-08 | — | — | EP | disclosed |
| EP-3468544-A2 | SYNERGISTIC ANTIFUNGAL COMPOSITIONS AND METHODS THEREOF | Vyome Therapeutics Limited (IN) | 2019-04-17 | — | — | EP | disclosed |
| EP-3458017-A1 | ORAL CARE COMPOSITIONS AND METHODS OF USE | Colgate-Palmolive Company (US) | 2019-03-27 | — | — | EP | disclosed |
| EP-3452014-A1 | SELF-ASSEMBLED GEL FOR CONTROLLED DELIVERY OF THERMOLABILE AGENTS | The Brigham and Women's Hospital, Inc. (US) | 2019-03-13 | — | — | EP | disclosed |
| WO-2018197050-A1 | RESINS DERIVED FROM RENEWABLE SOURCES AND STRUCTURES MANUFACTURED FROM SAID RESINS | BIO BOND APS (DK) | 2018-11-01 | — | — | WO | disclosed |
| WO-2018108921-A1 | MULTIPHASE CONDITIONING COMPOSITION WHOSE EFFECT IS PERSISTENT ON SHAMPOOING | L'OREAL (FR) | 2018-06-21 | — | — | WO | disclosed |
| EP-3288796-A1 | INTEGRATED THERMAL ENERGY MODULE WITHIN AN AIR-COOLED EVAPORATOR DESIGN | Thermo King Corporation (US) | 2018-03-07 | — | — | EP | disclosed |
| WO-2018009761-A1 | STABILIZED LIQUID FORMULATIONS CONTAINING PICOSULFATE | FERRING B.V. (NL) | 2018-01-11 | — | — | WO | disclosed |
| WO-2018005695-A1 | USE OF NEUROKININ-1 ANTAGONISTS TO TREAT A VARIETY OF PRURITIC CONDITIONS | MENLO THERAPEUTICS INC. (US) | 2018-01-04 | — | — | WO | disclosed |
| WO-2017223169-A1 | ORAL CARE COMPOSITIONS AND METHODS OF USE | COLGATE-PALMOLIVE COMPANY (US) | 2017-12-28 | — | — | WO | disclosed |
| WO-2017216722-A2 | SYNERGISTIC ANTIFUNGAL COMPOSITIONS AND METHODS THEREOF | VYOME BIOSCIENCES PVT. LTD. (IN) | 2017-12-21 | — | — | WO | disclosed |
| WO-2017193138-A1 | SELF-ASSEMBLED GEL FOR CONTROLLED DELIVERY OF THERMOLABILE AGENTS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2017-11-09 | — | — | WO | disclosed |
| EP-3237544-A1 | THERMOPLASTIC COMPOSITION HAVING HIGH FLUIDITY | Rhodia Operations (FR) | 2017-11-01 | — | — | EP | disclosed |
| EP-3180090-A1 | ORAL CARE COMPOSITIONS AND REGIMENS | The Procter and Gamble Company (US) | 2017-06-21 | — | — | EP | disclosed |
| EP-3160927-A1 | PROCESS FOR THE PREPARATION OF ETHYLENE GLYCOL FROM SUGARS | Haldor Topsøe A/S (DK) | 2017-05-03 | — | — | EP | disclosed |
| WO-2017040420-A1 | HEMORRHOID PREPARATION AND SHEETS | C.B. FLEET COMPANY, INCORPORATED (US) | 2017-03-09 | — | — | WO | disclosed |
| EP-3089854-A1 | SINGLE-PASS PROCESS FOR FORMING A MULTILAYERED SHAPED FILM PRODUCT | Johnson & Johnson Consumer Inc. (US) | 2016-11-09 | — | — | EP | disclosed |
| EP-3077060-A1 | TWO PART OXIDIZING SYSTEM FOR ORAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2016-10-12 | — | — | EP | disclosed |
| WO-2016102481-A1 | THERMOPLASTIC COMPOSITION HAVING HIGH FLUIDITY | RHODIA OPERATIONS (FR) | 2016-06-30 | — | — | WO | disclosed |
| WO-2016086102-A1 | SYSTEMS AND METHODS FOR INSOLUBLE OIL SEPARATION FROM AQUEOUS STREAMS TO PRODUCE PRODUCTS USING A HOLLOW-FIBER MEMBRANE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2016-06-02 | — | — | WO | disclosed |
| WO-2016025414-A1 | ORAL CARE COMPOSITIONS AND REGIMENS | THE PROCTER & GAMBLE COMPANY (US) | 2016-02-18 | — | — | WO | disclosed |
| WO-2016001136-A1 | PROCESS FOR THE PREPARATION OF ETHYLENE GLYCOL FROM SUGARS | HALDOR TOPSØE A/S (DK) | 2016-01-07 | — | — | WO | disclosed |
| EP-2931050-A1 | BOTANICAL ANTIMICROBIAL COMPOSITIONS | The Trustees of Columbia University in the City of New York (US) | 2015-10-21 | — | — | EP | disclosed |
| WO-2015084296-A1 | TWO PART OXIDIZING SYSTEM FOR ORAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2015-06-11 | — | — | WO | disclosed |
| EP-2830588-A1 | USE OF A LYSATE OF A CULTURE OF A BACTERIUM OF THE VITREOSCILLA SP. GENUS FOR PREVENTING AND/OR TREATING HYPERSEBORRHOEIC CONDITIONS OF THE SCALP | L'Oréal (FR) | 2015-02-04 | — | — | EP | disclosed |
| EP-2794773-A1 | HIGHLY STRUCTURED COMPOSITE MATERIAL AND PROCESS FOR THE MANUFACTURE OF PROTECTIVE COATINGS FOR CORRODING SUBSTRATES | Leibniz-Institut für Neue Materialien gemeinnützige GmbH (DE) | 2014-10-29 | — | — | EP | disclosed |
| EP-2794771-A1 | CORROSION RESISTANT EQUIPMENT FOR OIL AND/OR GAS APPLICATIONS | Tenaris Connections Ltd. (VC) | 2014-10-29 | — | — | EP | disclosed |
| WO-2014092999-A1 | BOTANICAL ANTIMICROBIAL COMPOSITIONS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2014-06-19 | — | — | WO | disclosed |
| WO-2013144869-A1 | USE OF A LYSATE OF A CULTURE OF A BACTERIUM OF THE VITREOSCILLA SP. GENUS FOR PREVENTING AND/OR TREATING HYPERSEBORRHOEIC CONDITIONS OF THE SCALP | L'OREAL (FR) | 2013-10-03 | — | — | WO | disclosed |
| US-20130251763-A1 | TRANSDERMAL COMPOSITIONS | MICRODERMIS CORPORATION (US) | 2013-09-26 | — | — | US | disclosed |
| CN-103251653-A | Method for processing byproducts of processing sea cucumber | KOREA INST SCI & TECH | 2013-08-21 | — | — | CN | disclosed |
| WO-2013091686-A1 | CORROSION RESISTANT EQUIPMENT FOR OIL AND/OR GAS APPLICATIONS | TENARIS CONNECTIONS LIMITED (VC) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013092841-A1 | HIGHLY STRUCTURED COMPOSITE MATERIAL AND PROCESS FOR THE MANUFACTURE OF PROTECTIVE COATINGS FOR CORRODING SUBSTRATES | LEIBNIZ-INSTITUT FÜR NEUE MATERIALIEN GEMEINNÜTZIGE GMBH (DE) | 2013-06-27 | — | — | WO | disclosed |
| EP-2482664-A2 | STORAGE-STABLE, SYNERGISTIC MICROBICIDAL CONCENTRATES CONTAINING AN ISOTHIAZOLONE, AN AMINE AND AN OXIDIZING AGENT | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2012-08-08 | — | — | EP | disclosed |
| US-20120022165-A1 | TRANSDERMAL COMPOSITIONS | MICRODERMIS CORPORATION (US) | 2012-01-26 | — | — | US | disclosed |
| WO-2011039088-A2 | STORAGE-STABLE MICROBICIDAL CONCENTRATES AND USE THEREOF AS PRESERVATIVES | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2011-04-07 | — | — | WO | disclosed |
| EP-2273972-A2 | TERNARY AND QUATERNARY WAX-RESIN COMPOSITES FOR USE IN COSMETIC AND PHARMACEUTICAL PREPARATIONS | Kobo Products Inc. (US) | 2011-01-19 | — | — | EP | disclosed |
| US-7790905-B2 | Pharmaceutical propylene glycol solvate compositions | MCNEIL-PPC, INC. (US) | 2010-09-07 | — | — | US | disclosed |
| EP-2217228-A1 | SOLID PHARMACEUTICAL COMPOSITION COMPRISING TAMSULOSIN | Krka, Torvarna Zdravil, D.D., Novo Mesto (SI) | 2010-08-18 | — | — | EP | disclosed |
| US-20100203005-A1 | TRANSDERMAL COMPOSITIONS | DRS. SOLUTIONS, LLC (US) | 2010-08-12 | — | — | US | disclosed |
| US-20100197795-A1 | TRANSDERMAL COMPOSITIONS | DRS. SOLUTIONS, LLC (US) | 2010-08-05 | — | — | US | disclosed |
| EP-2205710-A1 | DEWAXING PROCESS | Givaudan SA (CH) | 2010-07-14 | — | — | EP | disclosed |
| WO-2009126854-A2 | TERNARY AND QUATERNARY WAX-RESIN COMPOSITES FOR USE IN COSMETIC AND PHARMACEUTICAL PREPARATIONS | KOBO PRODUCTS INC. (US) | 2009-10-15 | — | — | WO | disclosed |
| WO-2009047312-A1 | SOLID PHARMACEUTICAL COMPOSITION COMPRISING TAMSULOSIN | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO (SI) | 2009-04-16 | — | — | WO | disclosed |
| WO-2009033306-A1 | DEWAXING PROCESS | GIVAUDAN SA (CH) | 2009-03-19 | — | — | WO | disclosed |
| EP-1919284-A1 | USE OF ISOEUGENOL METHYL ETHER AS AN AGENT AGAINST BAD BREATH | Symrise GmbH & Co. KG (DE) | 2008-05-14 | — | — | EP | disclosed |
| WO-2007141743-A2 | A TABLET DOSAGE FORM COMPRISING CETIRIZINE AND PSEUDOEPHEDRINE | RANBAXY LABORATORIES LIMITED (IN) | 2007-12-13 | — | — | WO | disclosed |
| EP-1817048-A2 | STABLE FORMULATIONS OF INSULINOPTROPIC PEPTIDES | NOVO NORDISK A/S (DK) | 2007-08-15 | — | — | EP | disclosed |
| EP-1812073-A1 | DELIVERY SYSTEM FOR TOPICALLY APPLIED COMPOUNDS | LIPO CHEMICALS INC (US) | 2007-08-01 | — | — | EP | disclosed |
| EP-1804848-A2 | IMPLANTABLE DEVICES COMPRISING BIOLOGICALLY ABSORBABLE STAR POLYMERS AND METHODS FOR FABRICATING THE SAME | Abbott Cardiovascular Systems, Inc. (US) | 2007-07-11 | — | — | EP | disclosed |
| EP-1784176-A1 | COMPOSITION COMPRISING LACTIC ACID AND LACTOFERRIN | Nestor Medical AB (SE) | 2007-05-16 | — | — | EP | disclosed |
| US-20070015841-A1 | Pharmaceutical propylene glycol solvate compositions | TRANSFORM PHARMACEUTICALS, INC. (US) | 2007-01-18 | — | — | US | disclosed |
| EP-1094781-A4 | COMPOSITIONS FOR RAPID AND NON-IRRITATING TRANSDERMAL DELIVERY OF PHARMACEUTICALLY ACTIVE AGENTS AND METHODS FOR FORMULATING SUCH COMPOSITIONS AND DELIVERY THEREOF | TRANSDERMAL TECHNOLOGIES INC (US) | 2007-01-17 | — | — | EP | disclosed |
| EP-1677802-A2 | 1,3 ACLYATED 24-KETO-VITAMIN D3 COMPOUNDS AND METHODS OF USE THEREOF | Bioxell S.p.a. (IT) | 2006-07-12 | — | — | EP | disclosed |
| WO-2006051110-A2 | STABLE FORMULATIONS OF INSULINOPTROPIC PEPTIDES | NOVO NORDISK A/S (DK) | 2006-05-18 | — | — | WO | disclosed |
| WO-2006049907-A2 | IMPLANTABLE DEVICES COMPRISING BIOLOGICALLY ABSORBABLE STAR POLYMERS | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2006-05-11 | — | — | WO | disclosed |
| WO-2006036557-A1 | DELIVERY SYSTEM FOR TOPICALLY APPLIED COMPOUNDS | LIPO CHEMICALS, INC. (US) | 2006-04-06 | — | — | WO | disclosed |
| WO-2006032664-A1 | USE OF ISOEUGENOL METHYL ETHER AS AN AGENT AGAINST BAD BREATH | SYMRISE GMBH & CO. KG (DE) | 2006-03-30 | — | — | WO | disclosed |
| EP-1638399-A1 | ADJUVANT FORMULATION FOR ENHANCING THE FUNGICIDAL EFFICACY AND FUNGICIDAL COMPOSITION CONTAINING SAME | Korea Research Institute of Chemical Technology (KR) | 2006-03-29 | — | — | EP | disclosed |
| WO-2006005823-A1 | DISPERSION OF ETHYLENE POLYMER PARTICLES, COMPOSITION CONTAINING SAME AND TREATMENT METHOD | L'OREAL (FR) | 2006-01-19 | — | — | WO | disclosed |
| WO-2006005824-A1 | DISPERSION OF ETHYLENE POLYMER PARTICLES, COMPOSITION CONTAINING SAME AND TREATMENT METHOD | L'ORÉAL (FR) | 2006-01-19 | — | — | WO | disclosed |
| WO-2006001766-A1 | COMPOSITION COMPRISING LACTIC ACID AND LACTOFERRIN | NESTOR MEDICAL AB (SE) | 2006-01-05 | — | — | WO | disclosed |
| WO-2006000658-A1 | DISPERSION OF ETHYLENE POLYMER PARTICLES, COMPOSITION CONTAINING SAME AND METHOD FOR TREATMENT | L'OREAL (FR) | 2006-01-05 | — | — | WO | disclosed |
| EP-1576092-A2 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 2005-09-21 | — | — | EP | disclosed |
| EP-1575631-A1 | COATING FOR IMPLANTABLE DEVICES AND A METHOD OF FORMING THE SAME | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2005-09-21 | — | — | EP | disclosed |
| WO-2005002336-A1 | ADJUVANT FORMULATION FOR ENHANCING THE FUNGICIDAL EFFICACY AND FUNGICIDAL COMPOSITION CONTAINING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2005-01-13 | — | — | WO | disclosed |
| US-6835374-B2 | Fine particle size; mixing, suspension active material with surfactant | REHEIS, INC. | 2004-12-28 | — | — | US | disclosed |
| WO-2004098507-A2 | 1,3 ACLYATED 24-KETO-VITAMIN D3 COMPOUNDS AND METHODS OF USE THEREOF | BIOXELL S.P.A. (IT) | 2004-11-18 | — | — | WO | disclosed |
| WO-2004060428-A1 | COATING FOR IMPLANTABLE DEVICES AND A METHOD OF FORMING THE SAME | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2004-07-22 | — | — | WO | disclosed |
| WO-2004057966-A1 | COMPOSITIONS AND METHODS FOR CONTROL OF BOVINE MASTITIS | SOLUTION BIOSCIENCES, INC. (US) | 2004-07-15 | — | — | WO | disclosed |
| WO-2004007536-A2 | INTERACTIONS OF THE EPSTEIN-BARR VIRUS PROTEIN EBNA1, AND USES THEREOF | AFFINIUM PHARMACEUTICALS, INC. (CA) | 2004-01-22 | — | — | WO | disclosed |
| WO-2003083068-A2 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 2003-10-09 | — | — | WO | disclosed |
| CN-1118280-C | Bioactive concentrate, method for producing same and certain pharmaceutical compositions also containing chondroitin sulfate | S C TEHMAN SRL (RO) | 2003-08-20 | — | — | CN | disclosed |
| CN-1118280-C | Bioactive concentrate, method for producing same and certain pharmaceutical compositions also containing chondroitin sulfate | S C TEHMAN SRL (RO) | 2003-08-20 | — | — | CN | disclosed |
| WO-2003010316-A1 | BACTERIOPHAGE-MEDIATED LYSIS ANTHRAX BACTERIA | PHAGE GENOMICS INC. (US) | 2003-02-06 | — | — | WO | disclosed |
| EP-0820293-B1 | BIOACTIVE CONCENTRATE, ITS PRODUCING METHOD AND CERTAIN DRUG COMPOSITIONS CONTAINING ALSO CHONDROITIN SULPHATE | S C TEHMAN SRL (RO) | 2002-10-23 | — | — | EP | disclosed |
| WO-2001009192-A9 | HUMAN MONOCLONAL ANTIBODIES TO PROSTATE SPECIFIC MEMBRANE ANTIGEN | MEDAREX INC (US) | 2002-09-12 | — | — | WO | disclosed |
| EP-1145209-A3 | LOW RESILIENCE, LOW FREQUENCY MOLDED POLYURETHANE FOAM | BAYER ANTWERPEN N.V. (BE) | 2002-03-06 | — | — | EP | disclosed |
| EP-1145209-A2 | LOW RESILIENCE, LOW FREQUENCY MOLDED POLYURETHANE FOAM | BAYER ANTWERPEN N.V. (BE) | 2001-10-17 | — | — | EP | disclosed |
| WO-2001055455-A2 | RESISTANCE SEQUENCES AND USES THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2001-08-02 | — | — | WO | disclosed |
| EP-1094781-A1 | COMPOSITIONS FOR RAPID AND NON-IRRITATING TRANSDERMAL DELIVERY OF PHARMACEUTICALLY ACTIVE AGENTS AND METHODS FOR FORMULATING SUCH COMPOSITIONS AND DELIVERY THEREOF | Transdermal Technologies Inc. (US) | 2001-05-02 | — | — | EP | disclosed |
| EP-1047449-A1 | IMMUNOLOGICAL COMPOSITIONS AND METHODS OF USE TO TRANSIENTLY ALTER MAMMALIAN CENTRAL NERVOUS SYSTEM MYELIN TO PROMOTE NEURONAL REGENERATION | UNIVERSITY OF BRITISH COLUMBIA (CA) | 2000-11-02 | — | — | EP | disclosed |
| WO-2000017836-A2 | LOW RESILIENCE, LOW FREQUENCY MOLDED POLYURETHANE FOAM | BAYER ANWERPEN N.V. (BE) | 2000-03-30 | — | — | WO | disclosed |
| WO-2000012695-A1 | NOVEL THERAPEUTIC MOLECULES AND USES THEREFOR | MONASH UNIVERSITY (AU) | 2000-03-09 | — | — | WO | disclosed |
| WO-1999049774-A9 | METHODS FOR THE DIAGNOSIS AND TREATMENT OF LUNG CANCER | GENZYME CORP (US) | 2000-02-24 | — | — | WO | disclosed |
| WO-2000001351-A1 | COMPOSITIONS FOR RAPID AND NON-IRRITATING TRANSDERMAL DELIVERY OF PHARMACEUTICALLY ACTIVE AGENTS AND METHODS FOR FORMULATING SUCH COMPOSITIONS AND DELIVERY THEREOF | TRANSDERMAL TECHNOLOGIES, INC. (US) | 2000-01-13 | — | — | WO | disclosed |
| WO-1999051194-A1 | PACKAGED HAIR COLOURING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1999-10-14 | — | — | WO | disclosed |
| WO-1999038887-A1 | DIVERGENT HIV-1 PEPTIDES | UNIVERSAL HEALTHWATCH, INC. (US) | 1999-08-05 | — | — | WO | disclosed |
| WO-1999021581-A1 | IMMUNOLOGICAL COMPOSITIONS AND METHODS OF USE TO TRANSIENTLY ALTER MAMMALIAN CENTRAL NERVOUS SYSTEM MYELIN TO PROMOTE NEURONAL REGENERATION | STEEVES JOHN D (CA) | 1999-05-06 | — | — | WO | disclosed |
| WO-1999020127-A1 | 1-METHYLBUTYL AND 1-METHYLHEXYL ESTERS AS FLAVORING AGENTS AND METHODS FOR PREPARING AND USING SAME | BUSH BOAKE ALLEN INC. (US) | 1999-04-29 | — | — | WO | disclosed |
| EP-0873133-A1 | BIOLOGICALLY ACTIVE COMPOSITION COMPRISING CYCLOSPORINE | GS DEVELOPMENT AB (SE) | 1998-10-28 | — | — | EP | disclosed |
| WO-1998021312-A1 | HUMAN HEPATOCYTES IN THREE-DIMENSIONAL SUPPORT SYSTEMS | RPMS TECHNOLOGY LIMITED (GB) | 1998-05-22 | — | — | WO | disclosed |
| EP-0839186-A1 | A MODIFIED ENZYME WITH LIPOLYTIC ACTIVITY | NOVO NORDISK A/S (DK) | 1998-05-06 | — | — | EP | disclosed |
| CN-1181017-A | Bioactive concentrate, method for producing same and certain pharmaceutical compositions also containing chondroitin sulfate | S C TEHMAN SRL (RO) | 1998-05-06 | — | — | CN | disclosed |
| CN-1181017-A | Bioactive concentrate, method for producing same and certain pharmaceutical compositions also containing chondroitin sulfate | S C TEHMAN SRL (RO) | 1998-05-06 | — | — | CN | disclosed |
| EP-0820293-A1 | BIOACTIVE CONCENTRATE, ITS PRODUCING METHOD AND CERTAIN DRUG COMPOSITIONS CONTAINING ALSO CHONDROITIN SULPHATE | S.C.TEHMAN SRL (RO) | 1998-01-28 | — | — | EP | disclosed |
| EP-0820293-A1 | BIOACTIVE CONCENTRATE, ITS PRODUCING METHOD AND CERTAIN DRUG COMPOSITIONS CONTAINING ALSO CHONDROITIN SULPHATE | S.C.TEHMAN SRL (RO) | 1998-01-28 | — | — | EP | disclosed |
| WO-1997042823-A1 | USE OF ORGANOBORON COMPOUNDS AS ANTIFOULING AGENTS | AMERICAN CYANAMID COMPANY (US) | 1997-11-20 | — | — | WO | disclosed |
| EP-0807118-A2 | NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME | GILEAD SCIENCES, INC. (US) | 1997-11-19 | — | — | EP | disclosed |
| EP-0459769-B1 | Cleaning compositions providing improved mush reduction, mildness enhancement or both | UNILEVER PLC (GB) | 1997-08-06 | — | — | EP | disclosed |
| WO-1997019350-A1 | A METHOD AND A RINSE SOLUTION USED IN OPERATING INSTRUMENTS ANALYZING PROTEIN-CONTAINING BIOLOGICAL LIQUIDS | RADIOMETER MEDICAL A/S (DK) | 1997-05-29 | — | — | WO | disclosed |
| WO-1997004055-A1 | OXIME CONTAINING INHIBITORS FOR ACID PICKLING | HENKEL CORPORATION (US) | 1997-02-06 | — | — | WO | disclosed |
| WO-1997004079-A1 | A MODIFIED ENZYME WITH LIPOLYTIC ACTIVITY | NOVO NORDISK A/S (DK) | 1997-02-06 | — | — | WO | disclosed |
| WO-1997004078-A1 | A MODIFIED ENZYME WITH LIPOLYTIC ACTIVITY | NOVO NORDISK A/S (DK) | 1997-02-06 | — | — | WO | disclosed |
| WO-1997002042-A1 | BIOLOGICALLY ACTIVE COMPOSITION COMPRISING CYCLOSPORINE | GS DEVELOPMENT AB (SE) | 1997-01-23 | — | — | WO | disclosed |
| WO-1996032117-A1 | BIOACTIVE CONCENTRATE, ITS PRODUCING METHOD AND CERTAIN DRUG COMPOSITIONS CONTAINING ALSO CHONDROITIN SULPHATE | S.C. TEHMAN SRL (RO) | 1996-10-17 | — | — | WO | disclosed |
| WO-1996032117-A1 | BIOACTIVE CONCENTRATE, ITS PRODUCING METHOD AND CERTAIN DRUG COMPOSITIONS CONTAINING ALSO CHONDROITIN SULPHATE | S.C. TEHMAN SRL (RO) | 1996-10-17 | — | — | WO | disclosed |
| WO-1996023801-A2 | NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME | GILEAD SCIENCES, INC. (US) | 1996-08-08 | — | — | WO | disclosed |
| EP-0705254-A1 | PHENYL HETEROCYCLES AS CYCLOOXYGENASE-2 INHIBITORS | MERCK FROSST CANADA INC. (CA) | 1996-04-10 | — | — | EP | disclosed |
| US-5463098-A | Reacting antiperspirant with water soluble liquid diol by heating in water solution, adding zinc glycinate, removing water to recover powder | WESTWOOD CHEMICAL CORP. | 1995-10-31 | — | — | US | disclosed |
| WO-1995000501-A2 | PHENYL HETEROCYCLES AS CYCLOOXYGENASE-2 INHIBITORS | MERCK FROSST CANADA INC. (CA) | 1995-01-05 | — | — | WO | disclosed |
| EP-0425150-A2 | Ink additives for improved ink-jet performance | Hewlett-Packard Company (US) | 1991-05-02 | — | — | EP | disclosed |
| EP-0322448-A4 | A METHOD FOR THE PREPARATION OF \"NATURAL\" METHYL ANTHRANILATE | — | 1991-04-17 | — | — | EP | disclosed |
| EP-0420729-A1 | Preparation of homogene plant suspension and suspension obtained thereby | LABORATOIRES ARDEVAL (FR) | 1991-04-03 | — | — | EP | disclosed |
| EP-0356472-A1 | COSMETIC METHOD APPLYING AN EXTRACT OF THE AERIAL PARTS OF(cichorium intybus l ). | DIOT MICHEL (FR) | 1990-03-07 | — | — | EP | disclosed |
| EP-0351024-A2 | Process for the preparation of polyesters | STAMICARBON B.V. (NL) | 1990-01-17 | — | — | EP | disclosed |
| WO-1989006954-A1 | NOVEL COSMETIC COMPOSITIONS CONTAINING AN EXTRACT OF THE AERIAL PARTS OF CICHORIUM INTYBUS L | DIOT MICHEL (FR) | 1989-08-10 | — | — | WO | disclosed |
| EP-0326714-A2 | Three dimensional light-sensitive diazonium condensates | HOECHST CELANESE CORPORATION (US) | 1989-08-09 | — | — | EP | disclosed |
| EP-0326491-A1 | Cosmetic method using an extract of the aerial parts of cichorium intybus L. | Diot, Michel (FR) | 1989-08-02 | — | — | EP | disclosed |
| WO-1989006539-A1 | PROCESS FOR PREPARATION OF ALOE PRODUCTS | CARRINGTON LABORATORIES, INC. (US) | 1989-07-27 | — | — | WO | disclosed |
| EP-0313006-A2 | Fhotopolymerizable composition comprising an initiator combination of 1,4-or 9,10-Dimethoxyanthracene and a trihalomethyl-(3H)-quinazolin-4-one | HOECHST CELANESE CORPORATION (US) | 1989-04-26 | — | — | EP | disclosed |
| WO-1989000203-A1 | A METHOD FOR THE PREPARATION OF \"NATURAL\" METHYL ANTHRANILATE | BASF K & F CORP. (US) | 1989-01-12 | — | — | WO | disclosed |
| WO-1988005298-A1 | USE OF ANORECTAL COMPOSITIONS | CHERNOMORSKY SIMON A | 1988-07-28 | — | — | WO | disclosed |
| WO-1982004192-A1 | COMPOSITION AND METHOD FOR INHIBITING TERMINAL DEOXYRIBONUCLEOTIDYL TRANSFERASE ACTIVITY | MCCAFFREY RONALD | 1982-12-09 | — | — | WO | disclosed |
| WO-1981003025-A1 | UREA FORMALDEHYDE DISPERSIONS MODIFIED WITH HIGHER ALDEHYDES | CLEARY CHEM CORP W A (US) | 1981-10-29 | — | — | WO | disclosed |
| WO-1981003025-A1 | UREA FORMALDEHYDE DISPERSIONS MODIFIED WITH HIGHER ALDEHYDES | CLEARY CHEM CORP W A (US) | 1981-10-29 | — | — | WO | disclosed |